Cargando…

Outcomes after primary and repeat thermal ablation of hepatocellular carcinoma with or without liver transplantation

OBJECTIVES: Thermal ablation (TA) is an established treatment for early HCC. There is a lack of data on the efficacy of repeated TA for recurrent HCC, resulting in uncertainty whether good oncologic outcomes can be obtained without performing orthotopic liver transplantation (OLTx). This study analy...

Descripción completa

Detalles Bibliográficos
Autores principales: Serbanescu-Kele Apor de Zalán, Christiaan M. C., Ruiter, Simeon J. S., van den Berg, Aad P., Pennings, Jan Pieter, de Jong, Koert P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9123025/
https://www.ncbi.nlm.nih.gov/pubmed/35133486
http://dx.doi.org/10.1007/s00330-021-08515-3
_version_ 1784711473960845312
author Serbanescu-Kele Apor de Zalán, Christiaan M. C.
Ruiter, Simeon J. S.
van den Berg, Aad P.
Pennings, Jan Pieter
de Jong, Koert P.
author_facet Serbanescu-Kele Apor de Zalán, Christiaan M. C.
Ruiter, Simeon J. S.
van den Berg, Aad P.
Pennings, Jan Pieter
de Jong, Koert P.
author_sort Serbanescu-Kele Apor de Zalán, Christiaan M. C.
collection PubMed
description OBJECTIVES: Thermal ablation (TA) is an established treatment for early HCC. There is a lack of data on the efficacy of repeated TA for recurrent HCC, resulting in uncertainty whether good oncologic outcomes can be obtained without performing orthotopic liver transplantation (OLTx). This study analyses outcomes after TA, with a special focus on repeat TA for recurrent HCC, either as a stand-alone therapy, or in relationship with OLTx. METHODS: Data from a prospectively registered database on interventions for HCC in a tertiary hepatobiliary centre was completed with follow-up until December 2020. Outcomes studied were rate of recurrence after primary TA and after its repeat interventions, the occurrence of untreatable recurrence, OS and DSS after primary and repeat TA, and complications after TA. In cohorts matched for confounders, OSS and DSS were compared after TA with and without the intention to perform OLTx. RESULTS: After TA, 100 patients (56·8%) developed recurrent HCC, of whom 76 (76·0%) underwent up to four repeat interventions. During follow-up, 76·7% of patients never developed a recurrence unamenable to repeat TA or OLTx. OS was comparable after primary TA and repeat TA. In matched cohorts, OS and DSS were comparable after TA with and without the intention to perform OLTx. CONCLUSIONS: We found TA to be an effective and repeatable therapy for primary and recurrent HCC. Most recurrences can be treated with curative intent. There are patients who do well with TA alone without ever undergoing OLTx. KEY POINTS: • Recurrent HCC after primary TA can often be treated effectively with repeat TA. Survival after repeat TA is comparable to primary TA. • In matched cohorts, outcomes after TA with and without subsequent waitlisting for OLTx are comparable. • There are patients who do well for many years with primary and repeat TA alone; some despite multiple recurrences. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00330-021-08515-3.
format Online
Article
Text
id pubmed-9123025
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-91230252022-05-22 Outcomes after primary and repeat thermal ablation of hepatocellular carcinoma with or without liver transplantation Serbanescu-Kele Apor de Zalán, Christiaan M. C. Ruiter, Simeon J. S. van den Berg, Aad P. Pennings, Jan Pieter de Jong, Koert P. Eur Radiol Interventional OBJECTIVES: Thermal ablation (TA) is an established treatment for early HCC. There is a lack of data on the efficacy of repeated TA for recurrent HCC, resulting in uncertainty whether good oncologic outcomes can be obtained without performing orthotopic liver transplantation (OLTx). This study analyses outcomes after TA, with a special focus on repeat TA for recurrent HCC, either as a stand-alone therapy, or in relationship with OLTx. METHODS: Data from a prospectively registered database on interventions for HCC in a tertiary hepatobiliary centre was completed with follow-up until December 2020. Outcomes studied were rate of recurrence after primary TA and after its repeat interventions, the occurrence of untreatable recurrence, OS and DSS after primary and repeat TA, and complications after TA. In cohorts matched for confounders, OSS and DSS were compared after TA with and without the intention to perform OLTx. RESULTS: After TA, 100 patients (56·8%) developed recurrent HCC, of whom 76 (76·0%) underwent up to four repeat interventions. During follow-up, 76·7% of patients never developed a recurrence unamenable to repeat TA or OLTx. OS was comparable after primary TA and repeat TA. In matched cohorts, OS and DSS were comparable after TA with and without the intention to perform OLTx. CONCLUSIONS: We found TA to be an effective and repeatable therapy for primary and recurrent HCC. Most recurrences can be treated with curative intent. There are patients who do well with TA alone without ever undergoing OLTx. KEY POINTS: • Recurrent HCC after primary TA can often be treated effectively with repeat TA. Survival after repeat TA is comparable to primary TA. • In matched cohorts, outcomes after TA with and without subsequent waitlisting for OLTx are comparable. • There are patients who do well for many years with primary and repeat TA alone; some despite multiple recurrences. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00330-021-08515-3. Springer Berlin Heidelberg 2022-02-08 2022 /pmc/articles/PMC9123025/ /pubmed/35133486 http://dx.doi.org/10.1007/s00330-021-08515-3 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Interventional
Serbanescu-Kele Apor de Zalán, Christiaan M. C.
Ruiter, Simeon J. S.
van den Berg, Aad P.
Pennings, Jan Pieter
de Jong, Koert P.
Outcomes after primary and repeat thermal ablation of hepatocellular carcinoma with or without liver transplantation
title Outcomes after primary and repeat thermal ablation of hepatocellular carcinoma with or without liver transplantation
title_full Outcomes after primary and repeat thermal ablation of hepatocellular carcinoma with or without liver transplantation
title_fullStr Outcomes after primary and repeat thermal ablation of hepatocellular carcinoma with or without liver transplantation
title_full_unstemmed Outcomes after primary and repeat thermal ablation of hepatocellular carcinoma with or without liver transplantation
title_short Outcomes after primary and repeat thermal ablation of hepatocellular carcinoma with or without liver transplantation
title_sort outcomes after primary and repeat thermal ablation of hepatocellular carcinoma with or without liver transplantation
topic Interventional
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9123025/
https://www.ncbi.nlm.nih.gov/pubmed/35133486
http://dx.doi.org/10.1007/s00330-021-08515-3
work_keys_str_mv AT serbanescukeleapordezalanchristiaanmc outcomesafterprimaryandrepeatthermalablationofhepatocellularcarcinomawithorwithoutlivertransplantation
AT ruitersimeonjs outcomesafterprimaryandrepeatthermalablationofhepatocellularcarcinomawithorwithoutlivertransplantation
AT vandenbergaadp outcomesafterprimaryandrepeatthermalablationofhepatocellularcarcinomawithorwithoutlivertransplantation
AT penningsjanpieter outcomesafterprimaryandrepeatthermalablationofhepatocellularcarcinomawithorwithoutlivertransplantation
AT dejongkoertp outcomesafterprimaryandrepeatthermalablationofhepatocellularcarcinomawithorwithoutlivertransplantation